The global need for effective medicines is increasing, whilst the biology underlying new drug concepts is becoming increasingly complex. This meeting will outline how the research community is rising to address these challenges by following the early life cycle of new medicine concepts through 3 critical stages:
1) Identifying your target.
2) Drugging your target.
3) Gaining clinical insights.
Through this meeting, we bring together the research community working in the field of new medicine creation with interests in developing their translational research ideas and applying novel technologies and means of collaboration to address critical clinical needs. Join scientists from academia, pharma, biotech and CRO’s either in person or online to hear talks given by speakers at the cutting edge of their field and gain strategic insights into solutions for increasing the success of your therapeutic ideas.
Miltenyi Biotec is organising a presentation by Dr Olaf Hardt and Dr Daniel Schäfer on the Early identification of target candidates for pancreatic adenocarcinoma immunotherapy on Wednesday 30th June at 11:40 a.m.